Annual EBITDA
$2.73B$47.28M+1.76%
Summary
- Current Value
- As of today, DVA annual EBITDA is $2.73B, up +1.76% on
- Historical Performance
- DVA annual EBITDA is up +33.29% over the past 3 years, up +17.78% over the past 5 years
- All-Time High Comparison
- DVA annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DVA annual EBITDA is +33.29% above its 3-year low of $2.05B reached on an earlier date
- Sector Comparison
- DVA annual EBITDA is higher than 96.02% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.73B | +1.8% | +33.3% | +17.8% | +123.0% | |
| Quarterly EBITDA | $718.38M | +6.7% | +6.1% | +12.8% | +83.0% | |
| TTM EBITDA | $2.85B | +7.7% | +30.0% | +16.9% | +113.2% | |
| Price | $156.14 | +35.5% | +62.4% | +56.9% | +325.6% | |
| PE Ratio | 11.81 | -0.4% | -21.6% | +3.9% | -33.2% | |
| Annual Revenue | $13.64B | +6.5% | +17.5% | +18.1% | +111.6% | |
| Annual EPS | $9.51 | -11.3% | +66.7% | +48.9% | +382.8% | |
| $2.01B | +2.9% | +53.2% | +19.4% | +103.5% | ||
| Annual Net Income | $1.05B | -15.8% | +37.2% | +4.9% | +117.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.73B | at high | |
| 5Y | $2.73B | at high | |
| All | $2.73B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.05B | N/A | +33.3% |
| 5Y | $2.05B | +33.3% | |
| All | $21.90M | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of DVA?
- As of today, DVA annual EBITDA is $2.73B
- What is 1-year change in DVA annual EBITDA?
- DVA annual EBITDA is up +1.76% year-over-year
- What is 3-year change in DVA annual EBITDA?
- DVA annual EBITDA is up +33.29% over the past 3 years
- How far is DVA annual EBITDA from its all-time high?
- DVA annual EBITDA is currently at its all-time high
- How does DVA annual EBITDA rank versus sector peers?
- DVA annual EBITDA is higher than 96.02% of companies in Healthcare sector
- When is DVA next annual earnings release?
- The next annual earnings release for DVA is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$718.38M$20.24M-2.74%
Summary
- Current Value
- As of today, DVA quarterly EBITDA is $718.38M, down -2.74% on
- Historical Performance
- DVA quarterly EBITDA is up +6.73% year-over-year, up +6.09% over the past 3 years
- All-Time High Comparison
- DVA quarterly EBITDA is currently -2.74% below its historical high of $738.63M set on
- 3-Year Low Comparison
- DVA quarterly EBITDA is +18.56% above its 3-year low of $605.91M reached on
- Sector Comparison
- DVA quarterly EBITDA is higher than 95.86% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $718.38M | -2.7% | +6.7% | +6.1% | +12.8% | |
| Annual EBITDA | $2.73B | – | +1.8% | +33.3% | +17.8% | |
| TTM EBITDA | $2.85B | +1.6% | +7.7% | +30.0% | +16.9% | |
| Price | $156.14 | -11.9% | +35.5% | +62.4% | +56.9% | |
| PE Ratio | 11.81 | -21.0% | -0.4% | -21.6% | +3.9% | |
| Quarterly Revenue | $3.58B | +0.7% | +4.6% | +14.6% | +21.8% | |
| Quarterly EPS | $3.40 | -15.3% | +67.0% | +29.8% | +43.9% | |
| $553.19M | -3.1% | +11.6% | +13.2% | +18.7% | ||
| Quarterly Net Income | $269.39M | -21.5% | +12.1% | -12.9% | -15.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $738.63M | -2.7% | |
| 3Y | $738.63M | -2.7% | |
| 5Y | $738.63M | -2.7% | |
| All | $738.63M | -2.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $651.38M | +10.3% | |
| 3Y | $605.91M | +18.6% | |
| 5Y | $448.50M | +60.2% | |
| All | -$57.00M | +1360.3% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of DVA?
- As of today, DVA quarterly EBITDA is $718.38M
- What is DVA quarterly EBITDA most recent change?
- DVA quarterly EBITDA was down -2.74% on September 30, 2026
- What is 1-year change in DVA quarterly EBITDA?
- DVA quarterly EBITDA is up +6.73% year-over-year
- How far is DVA quarterly EBITDA from its all-time high?
- DVA quarterly EBITDA is currently -2.74% below its historical high of $738.63M set on June 30, 2026
- How does DVA quarterly EBITDA rank versus sector peers?
- DVA quarterly EBITDA is higher than 95.86% of companies in Healthcare sector
- When is DVA next earnings release?
- The next earnings release for DVA is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$2.85B$45.29M+1.62%
Summary
- Current Value
- As of today, DVA TTM EBITDA is $2.85B, up +1.62% on
- Historical Performance
- DVA TTM EBITDA is up +7.70% year-over-year, up +30.02% over the past 3 years
- All-Time High Comparison
- DVA TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DVA TTM EBITDA is +30.02% above its 3-year low of $2.19B reached on an earlier date
- Sector Comparison
- DVA TTM EBITDA is higher than 95.86% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.85B | +1.6% | +7.7% | +30.0% | +16.9% | |
| Annual EBITDA | $2.73B | – | +1.8% | +33.3% | +17.8% | |
| Quarterly EBITDA | $718.38M | -2.7% | +6.7% | +6.1% | +12.8% | |
| Price | $156.14 | -11.9% | +35.5% | +62.4% | +56.9% | |
| PE Ratio | 11.81 | -21.0% | -0.4% | -21.6% | +3.9% | |
| TTM Revenue | $14.17B | +1.1% | +6.4% | +18.9% | +22.3% | |
| TTM EPS | $13.22 | +11.5% | +36.1% | +107.3% | +51.0% | |
| $2.15B | +2.8% | +10.8% | +48.7% | +21.6% | ||
| TTM Net Income | $1.19B | +2.5% | +8.8% | +42.2% | -1.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.85B | at high | |
| 3Y | $2.85B | at high | |
| 5Y | $2.85B | at high | |
| All | $2.85B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.64B | N/A | +7.7% |
| 3Y | $2.19B | N/A | +30.0% |
| 5Y | $2.01B | +41.6% | |
| All | -$25.40M | >+9999.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of DVA?
- As of today, DVA TTM EBITDA is $2.85B
- What is DVA TTM EBITDA most recent change?
- DVA TTM EBITDA was up +1.62% on September 30, 2026
- What is 1-year change in DVA TTM EBITDA?
- DVA TTM EBITDA is up +7.70% year-over-year
- How far is DVA TTM EBITDA from its all-time high?
- DVA TTM EBITDA is currently at its all-time high
- How does DVA TTM EBITDA rank versus sector peers?
- DVA TTM EBITDA is higher than 95.86% of companies in Healthcare sector
- When is DVA next earnings release?
- The next earnings release for DVA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- DVA Official Website www.davita.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/927066/000092706626000004/0000927066-26-000004-index.htm
- DVA Profile on Yahoo Finance finance.yahoo.com/quote/DVA
- DVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dva
